Literature DB >> 8544549

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

K A Gwee1, J C Graham, M W McKendrick, S M Collins, J S Marshall, S J Walters, N W Read.   

Abstract

BACKGROUND: Although previous studies have shown that psychological disturbances are frequently associated with the irritable bowel syndrome (IBS), the relation was not necessarily cause and effect. The development of chronic bowel symptoms resembling IBS after an episode of acute gastroenteritis has allowed us to examine prospectively the role of psychological factors.
METHODS: 75 patients with acute gastroenteritis completed a series of psychometric tests soon after admission to hospital. Of these, 22 had persistent symptoms compatible with IBS after the acute illness, and in 20 of these the symptoms were still present at six months.
FINDINGS: At the time of their initial illness, patients who subsequently developed IBS symptoms had higher scores for anxiety, depression, somatisation, and neurotic trait than those who returned to normal bowel function. The psychometric scores had not changed when remeasured three months after the acute illness. Lactose malabsorption was not an important factor.
INTERPRETATION: These results support the hypothesis that psychological factors are important in IBS.

Entities:  

Mesh:

Year:  1996        PMID: 8544549     DOI: 10.1016/s0140-6736(96)90341-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  106 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  The putative role of inflammation in the irritable bowel syndrome.

Authors:  S M Collins; T Piche; P Rampal
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

3.  East meets West: infection, nerves, and mast cells in the irritable bowel syndrome.

Authors:  S M Collins; G Barbara
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 4.  Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.

Authors:  Uday C Ghoshal; Kok-Ann Gwee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

5.  Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring.

Authors:  J H Winston; Q Li; S K Sarna
Journal:  Neurogastroenterol Motil       Date:  2014-03-04       Impact factor: 3.598

6.  Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats.

Authors:  T G Moreels; R J Nieuwendijk; J G De Man; B Y De Winter; A G Herman; E A Van Marck; P A Pelckmans
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 7.  Post-infectious irritable bowel syndrome.

Authors:  Andrew W Dupont
Journal:  Curr Gastroenterol Rep       Date:  2007-10

8.  Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice.

Authors:  E F Verdú; P Bercik; M Verma-Gandhu; X-X Huang; P Blennerhassett; W Jackson; Y Mao; L Wang; F Rochat; S M Collins
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

Review 9.  Irritable bowel syndrome as a common precipitant of central sensitization.

Authors:  G Nicholas Verne; Donald D Price
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

10.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.